AAV‐Mediated Gene Therapy Restores Hearing in Patients with DFNB9 Deafness
Jieyu Qi(Medical Protective), Renjie Chai(Medical Protective), Yinyi Zhou(Zhongda Hospital Southeast University), Fangzhi Tan(Zhongda Hospital Southeast University), Xiaoyun Qian(Nanjing University of Chinese Medicine), Yilai Shu(Fudan University), Chaorong Yu(Cazenovia College), Chang Tan(Cazenovia College), Shanzhong Zhang(Cazenovia College), Lei Xu(Shandong University), Liyan Zhang(Ningxia Medical University), Ziyu Zhang(Zhongda Hospital Southeast University), Jiancheng Liu(Cazenovia College), Huawei Li(Fudan University), Lulu Jiang(Jiangxi University of Science and Technology), Lian‐Qiu Wu(Cazenovia College), Sijie Sun(Universitat Autònoma de Barcelona), Wenxiu Dong(Cazenovia College), Yicheng Lu(Nantong University), Yabo Zhai(Southeast University), Ling Lü(Zhongda Hospital Southeast University), Tian Chen(Zhongda Hospital Southeast University), Xia Gao(Heilongjiang University of Science and Technology), Huaien Song(Fosun Pharma (China)), Xuehan Yang(Zhongda Hospital Southeast University)
Cited by 176
Related Papers
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
|Nature Biotechnology|2014|1.5k
Mutations in <i>TUBB8</i> and Human Oocyte Meiotic Arrest
|New England Journal of Medicine|2016|324
AAV1-hOTOF gene therapy for autosomal recessive deafness 9: a single-arm trial
|The Lancet|2024|323
AAV-ie enables safe and efficient gene transfer to inner ear cells
|Nature Communications|2019|228
Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibition
|Nature Cell Biology|2024|198